HomeRecall LibraryMedication RecallsFDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)
FDA recall notice

FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)

FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)

What to do next

Read the issuing agency's notice carefully, compare the product identifiers, and follow the official remedy instructions. RecallDefense helps you keep watch, but the source agency's notice is the authority for action.

View source notice

Source attribution: FDA. Published Feb 3, 2022.

Continue Exploring Recall Coverage

Keep Watch After Today

Save a product and get notified when a new recall matches it.

Start Monitoring Free